NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1

Ahmed Abdelrazik Elmarakby, E. Dabbs Loomis, Jennifer S. Pollock, David M. Pollock

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Experiments were conducted to test the hypothesis that hypertension produced by chronic ET-1 infusion is mediated by NADPH oxidase-dependent superoxide production. Mean arterial pressure (MAP) was continuously monitored in male Sprague Dawley rats by telemetry. After baseline measurements, rats were placed on a high-salt diet (8% NaCl) and osmotic minipumps were implanted to infuse ET-1 (5 pmol/kg per minute intravenous) for 12 days. Control rats were maintained on the high-salt diet only. Separate groups of rats were also infused with ET-1 and given the superoxide dismutase mimetic, tempol (1 mmol/L), or the NADPH oxidase inhibitor, apocynin (1.5 mmol/L), in the drinking water. Infusion of ET-1 significantly increased MAP when compared with baseline values (132±3 versus 114±2 mm Hg, P<0.05). Neither tempol nor apocynin treatment had any effect on the increase in MAP produced by ET-1 when compared with baseline values (127±5 versus 113±2 and 130±3 versus 115±2 mm Hg, respectively). Plasma 8-isoprostane, an indicator of oxidative stress, was significantly increased in ET-1-infused rats compared with rats on a high-salt diet alone (128±33 versus 51±5 pg/mL; P<0.05). Both tempol and apocynin treatment significantly attenuated the ET-1-induced increase in plasma 8-isoprostane (72±10 and 61±6 pg/mL, respectively). Similarly, ET-1 infusion also significantly increased aortic superoxide production (chemiluminescence and dihydroethidium staining techniques), which was prevented by both tempol and apocynin. These data provide evidence that chronic ET-1 infusion increases vascular NADPH oxidase-dependent superoxide production but does not account for chronic ET-1-induced hypertension.

Original languageEnglish (US)
Pages (from-to)283-287
Number of pages5
JournalHypertension
Volume45
Issue number2
DOIs
StatePublished - Feb 1 2005

Fingerprint

NADPH Oxidase
8-epi-prostaglandin F2alpha
Oxidative Stress
Hypertension
Superoxides
Arterial Pressure
Salts
Diet
Telemetry
Luminescence
Drinking Water
Superoxide Dismutase
Blood Vessels
Sprague Dawley Rats
Staining and Labeling
acetovanillone
tempol

Keywords

  • Endothelin
  • Oxidative stress
  • Sodium

ASJC Scopus subject areas

  • Internal Medicine

Cite this

NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. / Elmarakby, Ahmed Abdelrazik; Loomis, E. Dabbs; Pollock, Jennifer S.; Pollock, David M.

In: Hypertension, Vol. 45, No. 2, 01.02.2005, p. 283-287.

Research output: Contribution to journalArticle

Elmarakby, Ahmed Abdelrazik ; Loomis, E. Dabbs ; Pollock, Jennifer S. ; Pollock, David M. / NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. In: Hypertension. 2005 ; Vol. 45, No. 2. pp. 283-287.
@article{7dc2f54ebc484d658fcde2a065d946b2,
title = "NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1",
abstract = "Experiments were conducted to test the hypothesis that hypertension produced by chronic ET-1 infusion is mediated by NADPH oxidase-dependent superoxide production. Mean arterial pressure (MAP) was continuously monitored in male Sprague Dawley rats by telemetry. After baseline measurements, rats were placed on a high-salt diet (8{\%} NaCl) and osmotic minipumps were implanted to infuse ET-1 (5 pmol/kg per minute intravenous) for 12 days. Control rats were maintained on the high-salt diet only. Separate groups of rats were also infused with ET-1 and given the superoxide dismutase mimetic, tempol (1 mmol/L), or the NADPH oxidase inhibitor, apocynin (1.5 mmol/L), in the drinking water. Infusion of ET-1 significantly increased MAP when compared with baseline values (132±3 versus 114±2 mm Hg, P<0.05). Neither tempol nor apocynin treatment had any effect on the increase in MAP produced by ET-1 when compared with baseline values (127±5 versus 113±2 and 130±3 versus 115±2 mm Hg, respectively). Plasma 8-isoprostane, an indicator of oxidative stress, was significantly increased in ET-1-infused rats compared with rats on a high-salt diet alone (128±33 versus 51±5 pg/mL; P<0.05). Both tempol and apocynin treatment significantly attenuated the ET-1-induced increase in plasma 8-isoprostane (72±10 and 61±6 pg/mL, respectively). Similarly, ET-1 infusion also significantly increased aortic superoxide production (chemiluminescence and dihydroethidium staining techniques), which was prevented by both tempol and apocynin. These data provide evidence that chronic ET-1 infusion increases vascular NADPH oxidase-dependent superoxide production but does not account for chronic ET-1-induced hypertension.",
keywords = "Endothelin, Oxidative stress, Sodium",
author = "Elmarakby, {Ahmed Abdelrazik} and Loomis, {E. Dabbs} and Pollock, {Jennifer S.} and Pollock, {David M.}",
year = "2005",
month = "2",
day = "1",
doi = "10.1161/01.HYP.0000153051.56460.6a",
language = "English (US)",
volume = "45",
pages = "283--287",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1

AU - Elmarakby, Ahmed Abdelrazik

AU - Loomis, E. Dabbs

AU - Pollock, Jennifer S.

AU - Pollock, David M.

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Experiments were conducted to test the hypothesis that hypertension produced by chronic ET-1 infusion is mediated by NADPH oxidase-dependent superoxide production. Mean arterial pressure (MAP) was continuously monitored in male Sprague Dawley rats by telemetry. After baseline measurements, rats were placed on a high-salt diet (8% NaCl) and osmotic minipumps were implanted to infuse ET-1 (5 pmol/kg per minute intravenous) for 12 days. Control rats were maintained on the high-salt diet only. Separate groups of rats were also infused with ET-1 and given the superoxide dismutase mimetic, tempol (1 mmol/L), or the NADPH oxidase inhibitor, apocynin (1.5 mmol/L), in the drinking water. Infusion of ET-1 significantly increased MAP when compared with baseline values (132±3 versus 114±2 mm Hg, P<0.05). Neither tempol nor apocynin treatment had any effect on the increase in MAP produced by ET-1 when compared with baseline values (127±5 versus 113±2 and 130±3 versus 115±2 mm Hg, respectively). Plasma 8-isoprostane, an indicator of oxidative stress, was significantly increased in ET-1-infused rats compared with rats on a high-salt diet alone (128±33 versus 51±5 pg/mL; P<0.05). Both tempol and apocynin treatment significantly attenuated the ET-1-induced increase in plasma 8-isoprostane (72±10 and 61±6 pg/mL, respectively). Similarly, ET-1 infusion also significantly increased aortic superoxide production (chemiluminescence and dihydroethidium staining techniques), which was prevented by both tempol and apocynin. These data provide evidence that chronic ET-1 infusion increases vascular NADPH oxidase-dependent superoxide production but does not account for chronic ET-1-induced hypertension.

AB - Experiments were conducted to test the hypothesis that hypertension produced by chronic ET-1 infusion is mediated by NADPH oxidase-dependent superoxide production. Mean arterial pressure (MAP) was continuously monitored in male Sprague Dawley rats by telemetry. After baseline measurements, rats were placed on a high-salt diet (8% NaCl) and osmotic minipumps were implanted to infuse ET-1 (5 pmol/kg per minute intravenous) for 12 days. Control rats were maintained on the high-salt diet only. Separate groups of rats were also infused with ET-1 and given the superoxide dismutase mimetic, tempol (1 mmol/L), or the NADPH oxidase inhibitor, apocynin (1.5 mmol/L), in the drinking water. Infusion of ET-1 significantly increased MAP when compared with baseline values (132±3 versus 114±2 mm Hg, P<0.05). Neither tempol nor apocynin treatment had any effect on the increase in MAP produced by ET-1 when compared with baseline values (127±5 versus 113±2 and 130±3 versus 115±2 mm Hg, respectively). Plasma 8-isoprostane, an indicator of oxidative stress, was significantly increased in ET-1-infused rats compared with rats on a high-salt diet alone (128±33 versus 51±5 pg/mL; P<0.05). Both tempol and apocynin treatment significantly attenuated the ET-1-induced increase in plasma 8-isoprostane (72±10 and 61±6 pg/mL, respectively). Similarly, ET-1 infusion also significantly increased aortic superoxide production (chemiluminescence and dihydroethidium staining techniques), which was prevented by both tempol and apocynin. These data provide evidence that chronic ET-1 infusion increases vascular NADPH oxidase-dependent superoxide production but does not account for chronic ET-1-induced hypertension.

KW - Endothelin

KW - Oxidative stress

KW - Sodium

UR - http://www.scopus.com/inward/record.url?scp=13144293998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13144293998&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000153051.56460.6a

DO - 10.1161/01.HYP.0000153051.56460.6a

M3 - Article

VL - 45

SP - 283

EP - 287

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -